SFRP1 and SFRP2 Dose-Dependently Regulate Midbrain Dopamine Neuron Development In Vivo and in Embryonic Stem Cells
Julianna Kele, Emma R Andersson, J Carlos Villaescusa, Lukas Cajanek, Clare L Parish, Sonia Bonilla, Enrique M Toledo, Vitezslav Bryja, Jeffrey S Rubin, Akihiko Shimono, Ernest Arenas
Stem Cells | WILEY-BLACKWELL | Published : 2012
Awarded by Swedish Research Council (DBRM)
Awarded by Ministry of Education, Youth and Sports of the Czech Republic
Awarded by NATIONAL CANCER INSTITUTE
We thank Carmen Ramirez-Castillejo, Helena Mira, and Carmen Salto, for support and assistance; Alessandra Nanni for secretarial help; Johan Glad for help with statistical analysis; Johnny Soderlund and Lottie Jansson-Sjostrand for additional assistance. This work was supported by grants from the Swedish Research Council (DBRM, VR2008:2811 and 3287), European Union (Neurostemcell and Eurostemcell), Swedish Foundation for Strategic Research (INGVAR and DBRM), Norwegian Research Council, and Karolinska Institute, National Health and Medical Research Council (NHMRC), Australia. J.K. was supported by the Swedish National Neuroscience Network. J.C.V. was supported by a FEBS Long-Term Fellowship. V. B. was supported by EMBO Installation Grant and Ministry of Education, Youth and Sports of the Czech Republic (MSM0021622430). C.L.P was supported by an NHMRC Career development Fellowship, Australia. J.K. is currently affiliated with Ludwig Institute for Cancer Research Ltd., Stockholm, Sweden; E.R.A. is currently affiliated with Department of Cellular and Molecular Biology, Karolinska Institute, Stockholm, Sweden; S.B. is currently affiliated with Instituto de Biomedicina de Sevilla, Hospital Virgen del Rocio, Sevilla, Spain; V.B. is currently affiliated with Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic, and Institute of Biophysics, Brno, Czech Republic.